Automated, high-resolution cellular retention and uptake studies in vitro

被引：69

作者：

Bjorke, Henrik ^{[1
]}

Andersson, Karl ^{[1
]}

机构：

[1] Uppsala Univ, Div Biomed Radiat Sci, Uppsala, Sweden

来源：

APPLIED RADIATION AND ISOTOPES | 2006年 / 64卷 / 08期

关键词：

cellular uptake; cellular retention; protein interactions; kinetics;

D O I：

10.1016/j.apradiso.2006.03.002

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

This report describes an automated method for the measurements of cellular retention and uptake of radiolabeled proteins interacting with cell-surface receptors on intact cancer cells. A complete uptake and retention measurement was performed in one cell dish using a rotating radioimmunoassay (RIA) principle. Compared to common manual measurements, rotating RIA saved both labor time and reagents and provided real-time binding traces with superior time-resolution. The rotating RIA retention profiles for different interactions agreed with retention times reported in the literature. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：901 / 905

页数：5

共 18 条

[1] Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient [J].

Adams, DJ ;

Wahl, ML ;

Flowers, JL ;

Sen, B ;

Colvin, M ;

Dewhirst, MW ;

Manikumar, G ;

Wani, MC .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) :145-154

[2] BINDING OF EPIDERMAL GROWTH FACTOR-DEXTRAN CONJUGATES TO CULTURED GLIOMA-CELLS [J].

ANDERSSON, A ;

HOLMBERG, A ;

CARLSSON, J ;

PONTEN, J ;

WESTERMARK, B .

INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (03) :439-444

[3] Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area [J].

Björke, H ;

Andersson, K .

APPLIED RADIATION AND ISOTOPES, 2006, 64 (01) :32-37

[4] The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan [J].

Braun, AH ;

Stark, K ;

Dirsch, O ;

Hilger, RA ;

Seeber, S ;

Vanhoefer, U .

ANTI-CANCER DRUGS, 2005, 16 (10) :1099-1108

[5] Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI) [J].

Bruskin, A ;

Sivaev, I ;

Persson, M ;

Lundqvist, H ;

Carlsson, J ;

Sjöberg, S ;

Tolmachev, V .

NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (02) :205-211

[6] EFFECTS OF I-131 EGF ON CULTURED HUMAN GLIOMA-CELLS [J].

CAPALA, J ;

PRAHL, M ;

SCOTTROBSON, S ;

PONTEN, J ;

WESTERMARK, B ;

CARLSSON, J .

JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (03) :201-210

[7] Tumour therapy with radionuclides: assessment of progress and problems [J].

Carlsson, J ;

Aronsson, EF ;

Hietala, SA ;

Stigbrand, T ;

Tennvall, J .

RADIOTHERAPY AND ONCOLOGY, 2003, 66 (02) :107-111

[8] Therapy with radiopharmaceuticals [J].

Carlsson, J ;

Forssell-Aronsson, E ;

Gliemlius, B ;

Mattson, S .

ACTA ONCOLOGICA, 2002, 41 (7-8) :623-628

[9] A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions [J].

Huber, W .

JOURNAL OF MOLECULAR RECOGNITION, 2005, 18 (04) :273-281

[10] Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model [J].

Miao, YB ;

Hoffman, TJ ;

Quinn, TP .

NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (05) :485-493

← 1 2 →